Tomohiro Katsumi

9PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Bio-fluidsRadiation therapyMedical infection agents (incl. prions)Proteomics and intermolecular interactions (excl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 28, 2026
Real-World Outcomes of Combined Carbon-Ion Radiotherapy and Systemic Immunotherapy for Hepatocellular Carcinoma (Atezolizumab Plus Bevacizumab or Durvalumab Plus Tremelimumab): A Single-Center Retrospective Study.

|Jan 16, 2026
Lyophilized mesenchymal stem cell-derived extracellular vesicles improve outcomes in acute liver failure models.

Fumiya Suzuki, Hiroaki Haga, Tatsutoshi Inuzuka

|Aug 28, 2025
Treatment Outcomes in Patients Receiving Carbon-Ion Radiotherapy Versus Hepatectomy for Hepatocellular Carcinoma (≥4 cm): A Retrospective Study in Japan.

Keita Maki, Hiroaki Haga, Tomohiro Katsumi

|Aug 14, 2025
Adverse Events After Carbon-Ion Radiotherapy (CIRT) for Hepatocellular Carcinoma and Risk Factors for Biliary Stricture After CIRT: A Retrospective Study.

Keita Maki, Hiroaki Haga, Tomohiro Katsumi

|Apr 26, 2025
Optimizing Cabozantinib Dosing in Unresectable Hepatocellular Carcinoma of 7-on/7-off Regimen.

Yudai Fujiwara, Hidekatsu Kuroda, Tamami Abe

|Aug 19, 2024
Identification of microbial antigens in liver tissues involved in the pathogenesis of primary biliary cholangitis using 16S rRNA metagenome analysis.

Tomohiro Katsumi, Hidenori Sato, Ryoko Murakami

Pageof 2

Frequent Collaborators

6 joint publications

Yoshiyuki Ueno

5 joint publications

Keita Maki

4 joint publications

Hiroaki Haga

1 joint publications

Hidenori Sato